These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28756978)

  • 1. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.
    Koh YW; Lee SJ; Park SY
    Pathol Res Pract; 2017 Sep; 213(9):1134-1138. PubMed ID: 28756978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Bougioukas G; Didilis V; Gatter KC; Harris AL;
    Br J Cancer; 2003 Sep; 89(5):877-85. PubMed ID: 12942121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
    Grimm M; Krimmel M; Hoefert S; Kraut W; Calgéer B; Biegner T; Teriete P; Munz A; Reinert S
    J Oral Pathol Med; 2016 May; 45(5):346-55. PubMed ID: 26403591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
    Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
    Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1.
    Kayser G; Kassem A; Sienel W; Schulte-Uentrop L; Mattern D; Aumann K; Stickeler E; Werner M; Passlick B; zur Hausen A
    Diagn Pathol; 2010 Apr; 5():22. PubMed ID: 20385008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival is linked to serum LDH and partly to tumour LDH-5 in NSCLC.
    Danner BC; Didilis VN; Wiemeyer S; Stojanovic T; Kitz J; Emmert A; Füzesi L; Schöndube FA
    Anticancer Res; 2010 Apr; 30(4):1347-51. PubMed ID: 20530451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
    Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS
    Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
    Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
    Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
    Berezowska S; Galván JA; Langer R; Bubendorf L; Savic S; Gugger M; Schmid RA; Marti TM
    Virchows Arch; 2017 Mar; 470(3):323-330. PubMed ID: 28062918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer.
    Li J; Wei Z; Li H; Dang Q; Zhang Z; Wang L; Gao W; Zhang P; Yang D; Liu J; Sun Y; Gao W
    Hum Pathol; 2015 Dec; 46(12):1821-8. PubMed ID: 26391572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas.
    McCleland ML; Adler AS; Deming L; Cosino E; Lee L; Blackwood EM; Solon M; Tao J; Li L; Shames D; Jackson E; Forrest WF; Firestein R
    Clin Cancer Res; 2013 Feb; 19(4):773-84. PubMed ID: 23224736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.
    Imai H; Kaira K; Mori K; Ono A; Akamatsu H; Matsumoto S; Taira T; Kenmotsu H; Harada H; Naito T; Murakami H; Endo M; Nakajima T; Yamada M; Takahashi T
    BMC Cancer; 2015 Dec; 15():989. PubMed ID: 26690494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
    Yaman B; Nart D; Ekren PK; Çok G; Veral A
    Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab.
    Taniguchi Y; Tamiya A; Isa SI; Nakahama K; Okishio K; Shiroyama T; Suzuki H; Inoue T; Tamiya M; Hirashima T; Imamura F; Atagi S
    Anticancer Res; 2017 Oct; 37(10):5857-5862. PubMed ID: 28982912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas.
    Luo Y; Yang Z; Li D; Liu Z; Yang L; Zou Q; Yuan Y
    Appl Immunohistochem Mol Morphol; 2017; 25(5):351-357. PubMed ID: 26657874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.